Concurrent Use of Calcium Channel Blockers

Pharmacological Considerations

Both nimodipine and amlodipine are dihydropyridine calcium channel blockers with significant peripheral arterial dilatory effects, as noted by the American College of Cardiology 1, 2

Using multiple calcium channel blockers together can cause additive effects on heart rate, especially when combined with beta blockers, according to the Journal of Crohn's and Colitis 3
The combination may lead to excessive hypotension, which is particularly concerning in patients with pre-existing cardiovascular conditions, as reported in Circulation 4
Potential adverse effects include severe hypotension, as noted in the Journal of the American College of Cardiology 5
Worsening heart failure in susceptible patients may occur, as reported by the American College of Cardiology 1

The American College of Cardiology/American Heart Association does not recommend combining multiple calcium channel blockers 1, 2
The combination of calcium channel blockers with beta blockers requires particular caution due to additive effects on heart rate, as noted by the Journal of Crohn's and Colitis 3
If a patient requires additional blood pressure control, consider alternative drug classes such as ACE inhibitors, ARBs, or thiazide diuretics rather than adding a second calcium channel blocker, as suggested by the American College of Cardiology 6

Patients with pre-existing cardiovascular conditions should avoid certain calcium channel blockers, and amlodipine is better tolerated in mild left ventricular dysfunction, as reported in Circulation 4

Close monitoring of heart rate is recommended when using multiple calcium channel blockers, as noted by the Journal of Crohn's and Colitis 3
Monitoring for signs of peripheral edema is also recommended, as suggested by the American College of Cardiology 6
Symptoms of hypotension, such as dizziness and lightheadedness, should be closely monitored, as reported in Circulation 4